Preview

Rational Pharmacotherapy in Cardiology

Advanced search

CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE

https://doi.org/10.20996/1819-6446-2015-11-1-40-44

Full Text:

Abstract

One of the three clinical examples of hospital thrombolysis using Russian thrombolytic agent recombinant protein comprising an amino acid sequence of staphylokinase is described. The trial was held in Chelyabinsk Regional Vascular Centre of specialized medical care for patients with acute coronary syndromes. Each of the three patients had similar reasons for systemic intravenous thrombolysis: hospitalization with ST-segment elevation myocardial infarction, unavailability of coronary interventions due to the X-ray operating room occupancy, high need for the reperfusion therapy in the setting of significant acute myocardial ischemia. In all the cases the pharmacologic reperfusion with recombinant protein comprising an amino acid sequence of staphylokinase was successful, hereafter percutaneous coronary interventions were performed. There were no complications registered.

About the Authors

K. A. Kireev
Road Clinical Hospital at Chelyabinsk station, JSC "Russian Railways", South Ural State Medical University
Russian Federation

Dovatora ul. 23, Chelyabinsk, 454048 Russia

Vorovskogo ul. 64, Chelyabinsk, 454092 Russia



A. V. Krasnopeev
Road Clinical Hospital at Chelyabinsk station, JSC "Russian Railways"
Russian Federation

Dovatora ul. 23, Chelyabinsk, 454048 Russia



S. V. Utkina
Road Clinical Hospital at Chelyabinsk station, JSC "Russian Railways"
Russian Federation

Dovatora ul. 23, Chelyabinsk, 454048 Russia



References

1. State program of the Russian Federation "Development of health." Order of the Government of the Russian Federation of December 24, 2012 N 2511-p Moscow. Available at: http://www.rg.ru/2012/12/31/zdravooxr-site-dok.html. Accessed by 09/12/2014. Russian (Государственная программа Российской Федерации «Развитие здравоохранения». Распоряжение Правительства Российской Федерации от 24 декабря 2012 г. N 2511-р г. Москва. Доступно на: http://www.rg.ru/2012/12/31/zdravooxr-site-dok.html. Проверено 09.12.2014).

2. Bokeria LA. Health Russia: Atlas. Moscow: NTsSSKh im. A. N. Bakuleva RAMN; 2013. Russian (Бокерия Л.А. Здоровье России: Атлас. М.: НЦССХ им. А. Н. Бакулева РАМН; 2013).

3. Report on the state of public health and health organizations on the results of the executive authorities of the Russian Federation in 2013. Available at: http://www.rosminzdrav.ru/ministry/61/22/stranitsa-979/doklad_2013. Accessed by 09/12/2014. (Доклад о состоянии здоровья населения и организации здравоохранения по итогам деятельности органов исполнительной власти субъектов Российской Федерации за 2013 год. Доступно на: http://www.rosminzdrav.ru/ministry/61/22/stranitsa-979/doklad_2013. Проверено 09.12.2014).

4. Mortality in Chelyabinsk Region: Statistical Yearbook. Chelyabinsk: Chelyabinskstat; 2014. Russian (Смертность населения Челябинской области: Статистический сборник. Челябинск: Челябинскстат; 2014).

5. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute miocardial infarction a quantitative review of 23 randomized trials. Lancet 2003; 361:13-20.

6. National guidelines for diagnosis and treatment of patients with acute myocardial infarction with STsegment elevation ECG. Kardiovaskulyarnaya Terapiya i Profilaktika 2007; 6 (8) Annex 1: 1-64. Russian (Национальные рекомендации по диагностике и лечению больных острым инфарктом миокарда с подъемом сегмента ST ЭКГ. Кардиоваскулярная Терапия и Профилактика 2007;6 (8) приложение 1: 1-64).


For citation:


Kireev K.A., Krasnopeev A.V., Utkina S.V. CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE. Rational Pharmacotherapy in Cardiology. 2015;11(1):40-44. (In Russ.) https://doi.org/10.20996/1819-6446-2015-11-1-40-44

Views: 480


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)